You searched for lung cancer | Page 38 of 168

New ChromaCode Collaboration to Improve NSCLC Biomarker Testing Access

Posted by Andy Lundin | Jan 8, 2024 | Lung Cancer |

ChromaCode will collaborate with Tennessee Oncology to test the performance of ChromaCode’s HDPCR NSCLC biomarker assay.

Posted by Andy Lundin | Jan 5, 2024 | Lung Cancer |

The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.

Next-generation sequencing is at the forefront of the precision medicine revolution, offering the promise to empower tailored patient care.

Posted by Andy Lundin | Dec 13, 2023 | Lung Cancer |

Freenome’s PROACT LUNG study is intended to validate the clinical performance of its blood test for lung cancer screening.

Posted by Andy Lundin | Dec 13, 2023 | Lung Cancer |

DELFI Diagnostics is supporting the recently introduced Lung Cancer Screening and Prevention Act (H.R. 6693).